Nothing written yet for this company.
No news written yet.
| Period | 358570 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | 0.0% | -3.0% | +3.0% |
| 1 month | -5.4% | +4.2% | -9.6% |
| 3 months | -41.4% | -22.5% | -18.9% |
| 6 months | -38.4% | -16.9% | -21.6% |
| Year to date | -54.1% | -12.1% | -42.0% |
| 1 year | -55.7% | +1.0% | -56.7% |
Closed at 9% of the way from its 52-week low (₩6,820) to its 52-week high (₩20,900).
GI Innovation, Inc. does research and development in science and engineering in South Korea. It is listed on KOSDAQ, was founded in 2017, is based in Seoul, and has revenue of under ten billion won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2017 |
| Korean name | 지아이이노베이션 | Head office | Seoul |
| Symbol | Last Price |
|---|---|
| 085660Chabiotech Co., Ltd. | ₩8,090 +2.1% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |
| 001060JW Pharmaceutical | ₩27,500 +1.3% |
| 456160G2GBIO, Inc. | ₩37,950 +5.7% |
| 019170Shinpoong Pharmaceutical Co., Ltd. | ₩10,010 -0.9% |
| 086900Medy-Tox, Inc. | ₩69,600 +0.4% |
| 397030April Bio Co., Ltd. | ₩17,800 +6.1% |
| 249420Ildong Pharm | ₩15,030 -0.5% |